Events › Healthcare & MedTech
Healthcare & MedTech
450
Attendees
A dedicated business development and investment summit uniting biotech CEOs, innovators, and biopharma executives with venture, crossover, and institutional investors to navigate capital formation, regulatory changes, and licensing.
Attendees: Institutional investors, equity research analysts, venture capitalists, investment bankers, and biotechnology executive C-suite leaders.
Exhibitor mix: Organized alphabetically as an aggregate list of participating companies, therapeutic R&D innovators, diagnostics firms, and investment funds.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
Miami Beach Convention CenterConvention centre · 45,672 m² · 4 halls
A reimagined, LEED Silver-certified convention center in Miami Beach featuring 500,000 sq ft of exhibition space, a 60,000 sq ft Grand Ballroom, 84 breakout rooms, and over 10 acres of outdoor space. Hosts major trade shows, conventions, and events.
📍 1901 Convention Ctr Dr, Miami Beach, FL 33139, US
Operated by Oak View Group (OVG) Venue Management
Organizer
Biotechnology Innovation OrganizationNonprofit · Washington, United States · Founded 1993
The premier global trade association representing biotechnology companies, industry leaders, and state biotechnology groups.
Exhibitor list
250 companies are exhibiting at BIO Investment & Growth Summit. A sample of 12 is shown below — unlock the full list to see all 250.
Also exhibits at PCI Days - International Trade Fair for Suppliers to the Pharmaceutical and Cosmetics Industries, ASMS Annual Meeting: Focus on Skin Cancer, BIOPLUS-INTERPHEX KOREA
238 more exhibitors at BIO Investment & Growth Summit.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
To discover emerging public and private life science companies, source early-stage licensing opportunities, and execute capital allocation deals via curated face-to-face networking.
Exhibitor categories
Speakers
123 speakers at BIO Investment & Growth Summit
CEO · Enveda
"Fireside Chat featuring Enveda’s CEO Viswa Colluru and UBS Analyst Mike Yee"
Analyst · UBS
"Fireside Chat featuring Enveda’s CEO Viswa Colluru and UBS Analyst Mike Yee"
CEO · Oncolytics
"Oncolytics (Nasdaq:ONCY)"
Jared Kelly is an accomplished lawyer and executive with a distinguished career in corporate law, particularly within the biotechnology sector. Mr. Kelly recently served as head of legal and corporate strategy at Ambrx and played a central role in its $2 billion sale to Johnson & Johnson. He has managed numerous transactions in the biotech space for companies at various stages of development. After leaving Ambrx, he has served as an advisor to multiple public and private drug development and pharmaceutical companies. Prior to becoming a biotech executive, Mr. Kelly was a sought-after public company lawyer who began his career with Kirkland & Ellis LLP, where he represented various public companies in securities offerings, IPOs and merger transactions. He also served as a partner at Lowenstein Sandler LLP, where his practice focused on representing biotechnology companies in financing transactions, mergers and acquisitions, and other complex transactions. Mr. Kelly received his J.D. and an LL.M. in Securities and Financial Regulation from Georgetown University Law Center, where he was the recipient of multiple honors and fellowships, including the Lane Evans Fellowship and Decrane Scholarship.
Also speaking at Fierce Biotech Week
Also speaking at OIS Retina Innovation Summit 2026
Managing Director · Myeloma Investment Fund
"Navigating the New Normal: Venture Investment Trends"
Senior Partner, Capital Formation · Flagship Pioneering
"Navigating the New Normal: Venture Investment Trends"
Lead Investor · Yosemite
"Navigating the New Normal: Venture Investment Trends"
SVB
"Navigating the New Normal: Venture Investment Trends"
Also speaking at DeviceTalks Minnesota, OIS Retina Innovation Summit 2026
Chief Executive Officer · Basking Biosciences
"Navigating the New Normal: Venture Investment Trends"
Vice President, Venture Investments · Johnson & Johnson Innovation
"Navigating the New Normal: Venture Investment Trends"
Founder · Miami Biotech Collective
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
Senior Managing Director, Genetic Medicines · Leerink Partners
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
Chief Financial Officer · Syncromune
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
Executive Director, Coulter Program & New Ventures · University of Miami
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
Chief Investment Officer · J.P. Morgan Life Science Private Capital
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
EVP & Chief Financial Officer · SAB Bio
"From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub"
+ 107 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions